Journal article icon

Journal article

Novel therapeutic targets in axial spondyloarthritis

Abstract:
Purpose of review Axial spondyloarthritis remains an area of significant unmet clinical need with only two immune pathways currently targeted by licenced therapies compared to other immune-mediated inflammatory joint disorders such as rheumatoid arthritis where a multitude of therapeutic options are available. This review will look at emerging therapeutic targets in axial spondyloarthritis beyond the neutralisation of IL-17A and TNF by monoclonal antibodies. Recent f... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1007/s40674-018-0095-1

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDORMS
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDORMS
Oxford college:
Exeter College
Role:
Author
ORCID:
0000-0002-2312-3754
Publisher:
Springer International Publishing
Journal:
Current Treatment Options in Rheumatology More from this journal
Volume:
4
Issue:
2
Pages:
174–182
Publication date:
2018-04-12
Acceptance date:
2018-04-12
DOI:
ISSN:
2198-6002
Keywords:
Pubs id:
pubs:845767
UUID:
uuid:d02ccec0-c1a9-46fe-beae-9ce059df8368
Local pid:
pubs:845767
Source identifiers:
845767
Deposit date:
2018-05-03

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP